Actinium Pharmaceuticals and Aveo Oncology have signed a research partnership for developing and analysing an ErbB3 (HER3)-targeting antibody radio-conjugate (ARC) for solid tumour treatment. Actinium’s Antibody Warhead Enabling (AWE) technology platform and its broad radiotherapy […]
Code Biotherapeutics and Takeda have entered a partnership and option agreement for designing and developing gene therapies to treat rare diseases. The targeted 3DNA non-viral genetic medicine delivery platform of Code Bio will be used […]
The Scottish subsidiary of vaccine maker Valneva has been awarded up to £20m funding for the research and development of vaccines including its Covid-19 jab. The investment from Scotland’s national economic development agency, Scottish Enterprise, […]
Electra Therapeutics has raised $84m in a Series B funding round to advance the clinical development of its lead product candidate ELA026. The financing round was led jointly by Westlake Village BioPartners and OrbiMed with […]
SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both […]